The predictive value of ¹⁸F-FDG PET/CT in an EGFR-mutated lung adenocarcinoma population.

ABSTRACT:

Background

A non-invasive, simple, and convenient method to evaluate the presence of epidermal growth factor receptor (EGFR) mutations is important for initial treatment decisions in lung adenocarcinoma.

Methods

We retrospectively reviewed 297 untreated primary lung adenocarcinoma patients with exact EGFR status. Based on their EGFR status, the patients were divided into a mutant-type group (138 patients) and wild-type group (159 patients). General patient characteristics and possible factors reflecting the status of EGFR were also evaluated.

Results

Of the 297 lung adenocarcinoma patients analyzed for EGFR status who underwent positron emission tomography (PET)/computed tomography (CT) between January 2013 and December 2017, mutatio

SUBMITTER: Wang J 

PROVIDER: S-EPMC9372223 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature